People: Pacira Pharmaceuticals Inc (PCRX.O)

PCRX.O on Nasdaq

66.05USD
17 Apr 2014
Price Change (% chg)

$-1.67 (-2.47%)
Prev Close
$67.72
Open
$67.12
Day's High
$68.90
Day's Low
$65.28
Volume
185,120
Avg. Vol
503,732
52-wk High
$83.41
52-wk Low
$24.70

Search Stocks

Scibetta, James 

Brief Biography

Mr. James S. Scibetta is Chief Financial Officer of Pacira Pharmaceuticals Inc. Prior to that, Mr. Scibetta was chief financial officer of Bioenvision, Inc. (NASDAQ: BIVN) from 2006 until its acquisition by Genzyme, Inc. in 2007. From 2001 to 2006, Mr. Scibetta was executive vice president and chief financial officer of Merrimack Pharmaceuticals, Inc., and he was a member of the board of directors of Merrimack from 1998 to 2004. Mr. Scibetta formerly served as a senior investment banker at Shattuck Hammond Partners, LLC and PaineWebber Inc., providing capital acquisition, merger and acquisition, and strategic advisory services to healthcare companies. He currently serves as chairman of the board and audit committee of Nephros, Inc. (NASDAQ: NEPH). Mr. Scibetta holds a B.S. in physics from Wake Forest University, and an M.B.A. in finance from the University of Michigan. He completed executive education studies in the Harvard Business School Leadership & Strategy in Pharmaceuticals and Biotechnology program.

Basic Compensation

Total Annual Compensation, USD Long-Term Incentive Plans, USD All Other, USD Fiscal Year Total, USD
418,100 -- 1,062,670 1,480,770

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

David Stack

3,173,910

James Scibetta

1,480,770

Lauren Riker

--

Taunia Markvicka

1,442,450

John Pratt

--

Gary Patou

436,660
As Of 30 Dec 2012
Search Stocks